MedicalResearch.com Interview with:
Timna Naftali MD
Specialist in Gastroenterology
Meir Hospital and Kupat Holim Clinic,
Tel Aviv University, Israel
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: In previous studies we could see that Crohn’s patients improve symptoms when taking cannabis but we did not have good data about actual inflammation.
So, in this study we added a colonoscopy to see if we can detect any change in inflammation. We also wanted to find a better mode of consuming cannabis, other than smoking.
MedicalResearch.com: What should readers take away from your report?
Response: The take home massage would be that cannabis may help the patients feel better, but is not a replacement of conventional medical therapy. It should be used as an adjuvant to other treatments in appropriate cases.
MedicalResearch.com: What recommendations do you have for future research as a result of this work?
Response: Regarding future research, there are many points that should be addressed:
- Cannabis in laboratory trials does have an anti-inflammatory effect. We have to find a way of translating this effect to clinical treatment
- What is the best way of administering cannabis? (We certainly do not want to recommend smoking)
- What is the best dose/combination?
- What are the long term effects?
- Which patients, if any, will benefit most?
UEG 2018 abstract:
Cannabis induces clinical response but no endoscopic response in Crohn’s disease patients
The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.